About Delpharm
Delpharm is a Healthcare company based in Paris (France) founded in 1988. Pharmaceutical CDMO services for finished dosage forms are provided. Its website delpharm.com draws about 24 thousand monthly visits. Delpharm offers products and services including Drug Development Services, Manufacturing Services, and Regulatory Affairs. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its legal entity is DELPHARM POZNAŃ SPÓŁKA AKCYJNA.
Company details
Delpharm was founded in 1988 and operates as a contract development and manufacturing organization in the pharmaceutical sector. Services encompass production of licensed products, generics, OTC items, dietary supplements, and veterinary products across solid, semi-solid, liquid, and specialty dosage forms. Packaging solutions are also offered. Ten manufacturing plants are maintained in various locations across France.
- Headquarters Paris, France
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website delpharm.com
- Social LinkedIn
- Legal Name Delpharm Poznań Spółka Akcyjna
- Latest Funding Round$969.04K (USD), Grant
Jun 2021
- InvestorsTikehau Capital
& 2 more
Products & Services of Delpharm
Delpharm offers a comprehensive portfolio of products and services, including Drug Development Services, Manufacturing Services, and Regulatory Affairs.
Services for developing new pharmaceutical products and formulations
Production of oral solids, liquids, and sterile pharmaceuticals
Support for pharmaceutical regulatory and quality management
Funding Insights of Delpharm
- Total Rounds 4
- Last Round Grant — $969,044
- Investors Count 3
All 4 funding rounds of Delpharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $969,044 | Grant | – | – | |
| Feb 2016 | Debt – Conventional | – | – | ||
| Jul 2011 | Debt – Conventional | – | – | ||
| Jun 2011 | Debt – Conventional | – | – | – |
3 investors in total: 3 institutional.
Investors in Delpharm
Delpharm has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Tikehau Capital, Ministry of Economy, Finance and Industrial and Digital Sovereignty and Ardian.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Debt and equity investments are managed by the private fund. | 2013 | tikehaucapital.com | London, United Kingdom | |
Private investment firm specializing in markets and partnerships. | ardian.com | |||
| economie.gouv.fr |
Investor details for Delpharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Delpharm
8 people are tracked at Delpharm (6 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Nicolas Leforestier | Chief Operating Officer | Leadership |
Sebastien Aguettant | CEO | Leadership |
Xavier Foulon | Head Of Quality Control | Leadership |
Stéphane Lepeu | Chief Commercial Officer | Leadership |
Damien Brossard | Chief Quality Officer | Leadership |
Tomasz Nieradko | Group ERP Project Director | Leadership |
Loïc Jacob | Analytical Expert, Analytical Project Lead | Team |
Pascal Maury | Directeur Des Fonctions Supports (supply Chain, Achats, It, Data Management) | Team |
Complete people profiles for Delpharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Delpharm
3 dated milestones of Delpharm across 33 years, from founding to its latest funding, stage changes and deals.
- Founded Delpharm is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $969K.
Web traffic of Delpharm
The website of Delpharm (delpharm.com) receives about 23.9K visits a month and ranks #1,375,825 among all websites worldwide, #1,783 in Biotechnology and Pharmaceuticals.
- Monthly visits23.9K
▲ 62.2% vs previous month
- Unique visitors6.9K
per month
- Global rank#1,375,825
among all websites
- Category rank#1,783
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit3.0
- Average visit1 min 04 sec
- DevicesDesktop 38% · Mobile 62%
Websites whose visitors overlap most with Delpharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nutrilo.de | 100% | #8,435,112 | View details | ||
| aenova-group.com | 99% | 23.2K | #1,470,071 | View details | |
| probiotical.com | 82% | 5.2K | #4,903,958 | View details | |
pharmamanufacture.eu | pharmamanufacture.eu | 56% | #2,702,927 | – | |
bioxa.fr | bioxa.fr | 54% | #1,298,454 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Delpharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Delpharm
Complete news archive for Delpharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delpharm
Delpharm was founded in 1988 and raised its 1st funding round 23 years after it was founded.
Delpharm is headquartered in Paris, France.
Delpharm was founded in 1988 and operates as a contract development and manufacturing organization in the pharmaceutical sector. Services encompass production of licensed products, generics, OTC items, dietary supplements, and veterinary products across solid, semi-solid, liquid, and specialty dosage forms. Packaging solutions are also offered. Ten manufacturing plants are maintained in various locations across France.
Delpharm offers Drug Development Services, Manufacturing Services, and Regulatory Affairs.
Delpharm has 3 investors. Key investors include Tikehau Capital, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and Ardian.
Delpharm operates through Delpharm Poznań Spółka Akcyjna.